Source: Annual Congress 2001 - Immune deficiencies and the lung in childhood
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Rüter, K. Magdorf, J. L. Casanova, K. Paul, U. Wahn (Berlin, Germany; Paris, France). Pulmonary infection with Mycobacterium avium in immunocompetent children without IFN-γ (interferon-gamma) or IL-12-receptor deficiency. Eur Respir J 2001; 16: Suppl. 31, 3435

Member's Comments

No comment yet.

Related content which might interest you: IL-4 subverts mycobacterial containment in Mycobacterium tuberculosis-infected human macrophages Source: Eur Respir J, 54 (2) 1802242; 10.1183/13993003.02242-2018 Year: 2019 Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018 Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease Source: Eur Respir J 2005; 26: 1092-1096 Year: 2005 Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1237-1238 Year: 2011 Contribution of a whole blood IFN-gamma release assay for diagnosis of M. tuberculosis infection in BCG-vaccinated children Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa Source: Eur Respir J 2001; 18: Suppl. 33, 480s Year: 2001 Deficient interleukin-17 production in response to Mycobacterium abscessus in cystic fibrosis Source: Eur Respir J 2016; 47: 990-993 Year: 2016 Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1238-1239 Year: 2011 Impaired host defense against Mycobacterium avium in mice with chronic granulomatous disease Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Mycobacterium abscessus respiratory infection: importance in immunosuppressed patients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA Source: Eur Respir J 2013; 42: 454-460 Year: 2013 Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Infection of the respiratory mucosa by Mycobacterium avium complex (MAC), Mycobacterium tuberculosis (MTB) and Mycobacterium smegmatis (MS) Source: Eur Respir J 2001; 18: Suppl. 33, 308s Year: 2001 Cytokine gene polymorphisms and mycobacterium tuberculosis: from infection to pulmonary disease Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006 ESAT-6/CFP-10 and PPD-stimulated cytokine production in patients with MTB infection Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease Year: 2007 Invasive Mycobacterium avium intracellulare infection Source: Eur Respir J 2006; 28: Suppl. 50, 312s Year: 2006 Early BCG vaccination is unrelated to pulmonary immunity against Mycobacterium tuberculosis in adults Source: Eur Respir J 2014; 44: 1087-1090 Year: 2014 Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in latent and active tuberculosis Source: Annual Congress 2008 - New tools in tuberculosis diagnosis Year: 2008 Re-activation of bovine tuberculosis in a patient treated with infliximab Source: Eur Respir J 2008; 32: 229-231 Year: 2008 Lymphocyte responses to Mycobacterium tuberculosis and Mycobacterium bovis are similar between BCG-vaccinated patients with cystic fibrosis and healthy controls Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020